P2Y12 inhibition in high bleeding risk patients: making the right decision in a complex setting-Reference-Cited by-同舟云学术

P2Y12 inhibition in high bleeding risk patients: making the right decision in a complex setting

Published:2023-08-08 Issue:7 Volume:9 Page:669-669
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Dimitriadis Kyriakos¹^ORCID,Pyrpyris Nikolaos¹^ORCID,Aznaouridis Konstantinos¹^ORCID,Tsioufis Konstantinos¹

Affiliation:

1. First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital , 115 27, Athens , Greece

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/ehjcvp/advance-article-pdf/doi/10.1093/ehjcvp/pvad056/51232155/pvad056.pdf

Reference6 articles.

1. Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk—a report from the SWEDEHEART registry;Tjerkaski;Eur Heart J Cardiovasc Pharmacother,2023

2. Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis;Valgimigli;Eur Heart J,2022

3. Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis;Kang;Eur Heart J,2023

4. Validation of high-risk features for stent-related ischemic events as endorsed by the 2017 DAPT guidelines;Ueki;JACC Cardiovasc Interv,2019

5. Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI;Wang;BMC Cardiovasc Disord,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative safety review of antithrombotic treatment options for patients with atrial fibrillation undergoing percutaneous coronary intervention;Expert Opinion on Drug Safety;2024-01-17

2. Balancing the risks of bleeding and ischaemia in myocardial infarction patients at high bleeding risk;European Heart Journal - Cardiovascular Pharmacotherapy;2023-09-22